Navigation Links
'Pan'demonium Over Non -stick Pans

Sydney: An Australian regulator of industrial chemicals has suggested that we may not be able to stomach what pans out following the prolonged use of non-stick frying// pans and baking trays; intake of harmful toxins present in non-stick cookware, could penetrate into our system causing health problems, they said.

The National Industrial Chemicals Notification and Assessment Scheme or NICNAS said it is concerned about the use of non-sticks pans for cooking especially in the developing nations.

The culprit is a chemical called perfluorooctanoic acid (pentadecafluorooctanoic acid) or PFO, which supports the production of coatings present on metal surfaces and non-stick cookware. There is a fear that PFOA could remain in small amounts in the finished product as a residue. As a result, Australian authorities have recommended that PFOA be phased out gradually.

A study conducted by the U.S. Environmental Protection Agency (EPA) portrayed that the chemical manages to remain in living organisms and the environment, impeding development. The study carried out on rats showed the effect of these harmful toxins on the development of generations.

Many companies in the developed nations have taken the responsibility of slowly doing away with PFOA. A paper published this year in the journal Environmental Science and Technology, explains how PFOA is released even when non-stick cookware and microwave popcorn bags are subject to normal heat.

NICNAS has cautioned consumers against the overheating of non-stick cookware, which would most certainly result in the release of toxins that can have an adverse effect.
'"/>




Page: 1

Related medicine news :

1. A non-stick danger
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pan demonium Over Non stick Pans

(Date:7/3/2009)...wish knows what it,s like being addicted to prescr... America,s "Other" Drug Problem Prescription Medic...d his story of addiction and recovery and how he g...om Center drug and alcohol rehabilitation progra...om/09-0703-NarcononMI_72dpi.jpg ) , *(Photo Capt...
(Date:7/3/2009)..., , FRIDAY, July 3 (HealthDay News) -- C...0 injuries every year in the United States, but ta...ers safe while enjoying the key summer holiday tra...tion, which runs several Georgia-based medical fac... , Obey all local laws regarding fireworks. If yo...
(Date:7/3/2009)...hree individuals have been recognized for leadersh...tition designed to reward workplace health and saf...g community released its 2009 Saxcies global safet...ange.org/saxcies-video . The winners and finalists...es to keeping others safe - are detailed here. , ...
(Date:7/3/2009)...reform details emerge, more entrepreneurs are wond...business insurance premiums. Now, they are getting...the Small Business Health Insurance Network to fin...s, Minn. (PRWEB) July 3, 2009 -- The health care r...h has entrepreneurs worried about how this will af...
Breaking Medicine News(10 mins):Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:Put Safety First on the 4th 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3
...to help researchers track a tracer chemical, monam...g to quit smoking. This enzyme has been found to p...lation // has two subtypes MAO A and B. The study...s' peripheral organs - the heart, kidneys, spleen ...
...given hope to severely short-sighted patients who ... lenses but are unsuited for laser treatment, two ...e, offered by the National University Hospital and...cally // implanting a special kind of contact lens...
... pre-existent belief, of children who had received... more often for other diseases, is a myth and noth... latest issue of JAMA. During the last 2 decades, ...e and routine vaccination schedules// have become...
...orn are low birth weight (less than 2.4kg or 5.5lb...severely disabling condition// as a result of bei...ally a marker for good health in infancy and later...n are missing the critical first few weeks of gest...
Other Medicine News:Health News:Myth Of Childhood Vaccinations Linked To Increased Hospitalization Busted 2Health News:Vitamins Found To Influence Birth Weight 2
(Date:6/29/2009)...l surgery patients achieved primary and secondary ...Newswire/ -- AcelRx Pharmaceuticals, Inc. today an...linical study evaluating the safety and efficacy o...ement of acute post-operative pain in patients req...mpared to placebo, patients receiving ARX-01 Sufen...
(Date:6/28/2009)...29 Sangamo BioSciences, ...research milestone has been achieved in its Resear...holly-owned member of the Roche Group, for the gen...or pharmaceutical protein production purposes usin...otein nuclease (ZFN) technology. Genentech scienti...
(Date:6/26/2009)...6, and OSAKA, Japan, June 27, 2009 ...today announced that Takeda Global Research & ...ates (U.S.) subsidiary received on June 26 (U.S. t... and Drug Administration (FDA) regarding the Compa...selective dipeptidyl peptidase IV (DPP-4) inhibito...
(Date:6/26/2009)...ted and New Genetic Mutations Acting Together-- ,... -- More pieces in the complex autism inheritance ...earch team including geneticists from The Children...nnsylvania School of Medicine and several collabo...erent genetic regions where rare copy number varia...
Breaking Medicine Technology:AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4Pot Cigarette Smoke Wreaks Havoc on Lungs 42349 1Pot Cigarette Smoke Wreaks Havoc on Lungs 42349 2National Physicians Study 3A Nearly One Third Would Choose Different Career Today 42345 1National Physicians Study 3A Nearly One Third Would Choose Different Career Today 42345 2Wristbands May Lessen Nausea After Radiation 42342 1Wristbands May Lessen Nausea After Radiation 42342 2Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 1Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 2Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 3Video 3A The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 42338 4
...t the , 2007 American Society of Clinical Oncology...Older Patients with AML and in,Refractory , ALL Pa...cular interaction of Aloxi(R),with , the 5-HT3 Rec...s of Glioblastoma Patients,Treated , with Multimod...urvival Analysis of Irofulven in Second-Line HRPC,...
...ewswire/ -- The Barbara,Ann Karmanos Cancer Instit...essor of medicine and oncology, presented the outc...creas cancer clinical,trials in North America and ...ancreatic cancer therapies at the American Society...cago, IL. , The clinical trial, A Phase III Random...
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability.
Medicine Products: